Cargando…

Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study

BACKGROUND: Creatinine-to-cystatin C ratio is recently suggested to be a surrogate marker for sarcopenia. However, little is known about its association with diabetes. This study aimed to fill in this gap based on a large-scale prospective cohort. METHODS: A population-based representative sample of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Shanhu, Cai, Xue, Xie, Bo, Yuan, Yang, Sun, Zilin, Wu, Tongzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171165/ https://www.ncbi.nlm.nih.gov/pubmed/35249274 http://dx.doi.org/10.4093/dmj.2021.0074

Ejemplares similares

Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study
por: Qiu, Shanhu, et al.
Publicado: (2022)

Comment on ‘Prediabetes is an independent risk factor for sarcopenia in older men, but not in older women: the Bunkyo Health Study’ by Kaga et al.
por: Qiu, Shanhu, et al.
Publicado: (2023)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: A retrospective cohort study from the China Health and Retirement Longitudinal Study
por: Wu, Yang, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults
por: Tan, Lingling, et al.
Publicado: (2020)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

Prediabetes Progression and Regression on Objectively-Measured Physical Function: A Prospective Cohort Study
por: Qiu, Shanhu, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture
por: Okubo, Naoki, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years
por: Zhang, Li, et al.
Publicado: (2023)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
por: Jung, Chan‐Young, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China
por: Zhong, Danrong, et al.
Publicado: (2022)

Two elderly patients with normal creatinine and elevated cystatin C – a case report
por: Loesment-Wendelmuth, Amina, et al.
Publicado: (2017)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in middle-aged and older adults: a cross-sectional study from NHANES database
por: Wang, Zhenwei, et al.
Publicado: (2023)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus
por: Gao, Ting, et al.
Publicado: (2022)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Creatinine and cystatin C: Shooting at a flying target
por: Chao, Chia-Ter
Publicado: (2011)

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2014)

Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation
por: Šálek, Tomáš, et al.
Publicado: (2020)

Estimated GFR Accuracy When Cystatin C– and Creatinine-Based Estimates Are Discrepant in Older Adults
por: Potok, O. Alison, et al.
Publicado: (2023)

The Utility of the Creatinine Excretion to Production Ratio and the Plasma Creatinine and Cystatin C Based Kinetic Estimates of Glomerular Filtration Rates in Critically Ill Patients with Sepsis
por: Md Ralib, Azrina, et al.
Publicado: (2022)

Hypertension and cystatin C account for sex differences in serum homocysteine levels in acute coronary syndrome subjects with normal serum creatinine
por: Shang, Kun, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
por: Wei, Wen, et al.
Publicado: (2022)

The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients
por: Khang, Ah Reum, et al.
Publicado: (2023)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
por: Yoshii, Ichiro, et al.
Publicado: (2023)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2023)

Validity of self-reported diabetes among middle-aged and older Chinese adults: the China Health and Retirement Longitudinal Study
por: Yuan, Xiaojing, et al.
Publicado: (2015)

Associations of sensory impairment and cognitive function in middle-aged and older Chinese population: The China Health and Retirement Longitudinal Study
por: Zhao, Xiaohuan, et al.
Publicado: (2021)

Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction
por: Qiu, Shanhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_slvdg14do3r7gs4r888nomps9n